Qtron Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $811K | Sell |
33,672
-694
| -2% | -$18.2K | 0.11% | 221 |
|
|
2026
Q1 | $965K | Hold |
34,366
| – | – | 0.13% | 191 |
|
|
2025
Q4 | $856K | Sell |
34,366
-1,443
| -4% | -$36.4K | 0.11% | 215 |
|
|
2025
Q3 | $912K | Sell |
35,809
-2,069
| -5% | -$51.1K | 0.11% | 209 |
|
|
2025
Q2 | $918K | Hold |
37,878
| – | – | 0.12% | 204 |
|
|
2025
Q1 | $960K | Sell |
37,878
-6,713
| -15% | -$176K | 0.14% | 181 |
|
|
2024
Q4 | $1.18M | Hold |
44,591
| – | – | 0.17% | 139 |
|
|
2024
Q3 | $1.29M | Hold |
44,591
| – | – | 0.18% | 137 |
|
|
2024
Q2 | $1.25M | Sell |
44,591
-11,670
| -21% | -$321K | 0.18% | 124 |
|
|
2024
Q1 | $1.56M | Hold |
56,261
| – | – | 0.22% | 95 |
|
|
2023
Q4 | $1.62M | Buy |
56,261
+16,993
| +43% | +$514K | 0.27% | 72 |
|
|
2023
Q3 | $1.3M | Sell |
39,268
-3,079
| -7% | -$109K | 0.25% | 86 |
|
|
2023
Q2 | $1.55M | Sell |
42,347
-6,774
| -14% | -$264K | 0.29% | 73 |
|
|
2023
Q1 | $2M | Sell |
49,121
-12,606
| -20% | -$544K | 0.41% | 52 |
|
|
2022
Q4 | $3.16M | Buy |
61,727
+11,234
| +22% | +$539K | 0.66% | 25 |
|
|
2022
Q3 | $2.21M | Sell |
50,493
-2,280
| -4% | -$111K | 0.55% | 33 |
|
|
2022
Q2 | $2.77M | Buy |
52,773
+8,851
| +20% | +$451K | 0.61% | 30 |
|
|
2022
Q1 | $2.27M | Sell |
43,922
-3,967
| -8% | -$206K | 0.51% | 41 |
|
|
2021
Q4 | $2.83M | Hold |
47,889
| – | – | 0.64% | 30 |
|
|
2021
Q3 | $2.06M | Buy |
47,889
+4,755
| +11% | +$211K | 0.55% | 41 |
|
|
2021
Q2 | $1.69M | Buy |
43,134
+13,603
| +46% | +$529K | 0.43% | 47 |
|
|
2021
Q1 | $1.07M | Sell |
29,531
-1,432
| -5% | -$50.8K | 0.3% | 74 |
|
|
2020
Q4 | $1.14M | Buy |
30,963
+14,152
| +84% | +$519K | 0.3% | 71 |
|
|
2020
Q3 | $585K | Hold |
16,811
| – | – | 0.2% | 120 |
|
|
2020
Q2 | $522K | Buy |
+16,811
| New | +$571K | 0.21% | 131 |
|
|
2019
Q4 | – | Sell |
-14,914
| Closed | -$508K | – | 256 |
|
|
2019
Q3 | $508K | Sell |
14,914
-11,591
| -44% | -$421K | 0.31% | 110 |
|
|
2019
Q2 | $1.09M | Buy |
26,505
+10,528
| +66% | +$418K | 0.68% | 29 |
|
|
2019
Q1 | $644K | Sell |
15,977
-4,489
| -22% | -$180K | 0.59% | 32 |
|
|
2018
Q4 | $848K | Buy |
+20,466
| New | +$850K | 0.65% | 19 |
|
Other funds holding PFE
Qtron Investments's PFE Position: Q2 2026 in Review
Qtron Investments reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $18.2K and leaving 33,672 shares worth $811K. The position accounts for 0.11% of the portfolio, ranked #221.
Qtron Investments first reported a position in PFE in Q4 2018 and has held it in 29 quarters since. The position peaked at $3.16M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Qtron Investments held 33,672 shares of Pfizer worth $811K as of Q2 2026.
- Qtron Investments sold 694 Pfizer shares in Q2 2026, an estimated $18.2K.
- Pfizer made up 0.11% of Qtron Investments's portfolio in Q2 2026, its #221 holding.
- Qtron Investments first reported a position in Pfizer in Q4 2018 and has held it in 29 quarters since.
- Qtron Investments's Pfizer position peaked at $3.16M in Q4 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.